Noetic Fund logo

Noetic Fund

North America, Ontario, Canada, Toronto

Description

Noetic Fund invests in early-stage psychedelic-based wellness, therapeutic and pharmaceutical companies.

Investor Profile

Noetic Fund has made 15 investments, with 0 in the past 12 months and 33% as lead.

Stage Focus

  • Series A (47%)
  • Series Unknown (20%)
  • Series B (13%)
  • Seed (13%)
  • Convertible Note (7%)

Country Focus

  • United States (73%)
  • United Kingdom (20%)
  • Canada (7%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical
  • Pharmaceutical
  • Personal Health
  • Mental Health
  • Wellness
  • Life Science
  • Information Technology
  • Retail
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Noetic Fund frequently co-invest with?

Gaingels
North America, Vermont, United States, Burlington
Co-Investments: 2
Dolby Family Ventures
North America, California, United States, San Francisco
Co-Investments: 1
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 2
Artis Ventures (AV)
North America, California, United States, San Francisco
Co-Investments: 1
BC
North America, California, United States, Santa Monica
Co-Investments: 3
PsyMed Ventures
North America, California, United States, San Francisco
Co-Investments: 4
PS
North America, Illinois, United States, Highland Park
Co-Investments: 2
Presight Capital
North America, California, United States, West Hollywood
Co-Investments: 2
Casa Verde Capital
North America, California, United States, Los Angeles
Co-Investments: 1
AH
North America, Massachusetts, United States, Boston
Co-Investments: 1

Which angels does Noetic Fund often collaborate with?

JM
North America, United States
Shared Deals: 1
RR
Europe, England, United Kingdom, London
Shared Deals: 1
VD
Europe, England, United Kingdom, London
Shared Deals: 1
PL
North America, California, United States, San Francisco
Shared Deals: 1
JM
Europe, Islas Baleares, Spain, San José
Shared Deals: 1
AK
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by Noetic Fund?

Apollo Neuroscience

Pittsburgh, Pennsylvania, United States

Apollo is a wellness product, the first clinically validated wearable that actively helps the body recover from stress.

RetailShoppingWellness
Series AMar 17, 2022
Amount Raised: $15,000,000
Tactogen

Palo Alto, California, United States

Tactogen is a biopharma startup that develops empathogen medicines.

BiopharmaBiotechnologyPharmaceutical
SeedJan 1, 2022
Terran Biosciences

New York, New York, United States

Terran Biosciences is developing therapeutics and technologies to change the lives of patients with neurological and psychiatric diseases.

BiotechnologyHealth CareMedicalNeuroscience
Series UnknownJan 1, 2022
Wake Network

Los Angeles, California, United States

Wake Network's mission is to create a world where natural psilocybin therapies are the primary support for mental health and wellness.

BiotechnologyHealth CareMedicalMental HealthProduct Research
Series ADec 14, 2021
Delix Therapeutics

Boston, Massachusetts, United States

Delix Therapeutics focuses on harnessing the power of psychoplastogens novel neuroplasticity-promoting therapeutic.

BiotechnologyHealth CareLife Science
Series ASep 27, 2021
Amount Raised: $70,000,000
Sana Health

Louisville, Colorado, United States

Sana Health is an audio-visual neuromodulation device, that provides anxiety relief on-demand.

Consumer ElectronicsHealth CareInformation TechnologyMedical DevicePersonal HealthWearables
Convertible NoteSep 1, 2021
Amount Raised: $4,200,000
Merlyn Mind

New York, New York, United States

Merlyn Mind is a technology company that provides AI-based solutions to various industries.

Artificial Intelligence (AI)Information TechnologySoftware Engineering
Series UnknownJun 21, 2021
Amount Raised: $29,000,000
Apollo Neuroscience

Pittsburgh, Pennsylvania, United States

Apollo is a wellness product, the first clinically validated wearable that actively helps the body recover from stress.

RetailShoppingWellness
Series AMay 21, 2021
Amount Raised: $6,000,000
Gilgamesh Pharmaceuticals

New York, New York, United States

Gilgamesh Pharmaceuticals provides medicines for psychedelic, novel psychotropic drugs, depression, anxiety, and stress-related disorders.

BiotechnologyHealth CareMedicalPharmaceutical
Series AMay 6, 2021
Amount Raised: $27,000,000
Bexson Biomedical

Santa Barbara, California, United States

Bexson Biomedical is developing a unique formulation of ketamine for chronic and acute pain disorders.

Health CarePharmaceutical
Series AFeb 2, 2021
Amount Raised: $4,800,000